Assessment of the Utility of Selected Inflammatory Markers in Correlation with Magnetic Resonance Enterography (MRE) Findings in the Diagnosis of Crohn’s Disease
Open Access
- 13 January 2025
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 15 (1) , 116
Abstract
Crohn’s Disease (CD) is a chronic inflammatory bowel disease affecting the gastrointestinal tract. The search continues for new markers for assessing the activity of CD. Among them, pro-inflammatory and anti-inflammatory cytokines appear promising. We performed the analysis of cytokine concentrations in blood serum using the Bio-Plex Multiplex system (Bio-Rad), and their correlations with radiological parameters were assessed by magnetic resonance enterography (MRE), and fecal calprotectin levels were measured quantitatively by ELISA and clinical evaluation according to the Crohn’s Disease Activity Index (CDAI). Our study found that measuring cytokine serum concentrations can be a valuable tool in the diagnosis and treatment of CD. Positive correlations were reported between contrast enhancement on DCE-MRE and the concentrations of PDGF-BB and RANTES. Also, a positive correlation was found between the delayed-phase of DCE and IL-10 concentration, a strong negative correlation between the delayed-phase of DCE and IL-12 concentration, and a strong positive correlation between the delayed-phase of DCE and RANTES concentrations. A strong positive correlation was also observed between the thickness of the intestinal wall on T2-weighted images and RANTES concentration. Therefore, concentrations of PDGF-BB, RANTES, IL-10 and IL-12 are promising markers of CD activity. The study also demonstrated significant correlations between the severity of disease activity assessed by the CDAI and the concentrations of IL-5, IL-8 and IL-9, as well as positive correlations between the levels of fecal calprotectin and the concentrations of IL-1RA and VEGF. Therefore, the levels of IL-5, IL-8, IL-9, VEGF and IL-1RA may be useful markers in the diagnosis and clinical assessment of disease activity.Keywords
All Related Versions
Funding Information
- own funds (KNW-1-097/N/9/0)
This publication has 56 references indexed in Scilit:
- The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet Gastroenterology & Hepatology, 2020
- Cytokine Networks in the Pathophysiology of Inflammatory Bowel DiseaseImmunity, 2019
- Colorectal cancer in inflammatory bowel disease: review of the evidenceTechniques in Coloproctology, 2019
- Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseasesInternational Journal of Colorectal Disease, 2018
- An Update on Inflammatory Bowel DiseasePrimary Care: Clinics in Office Practice, 2017
- Association of serum VEGF with clinical response to anti-TNFα therapy for Crohn’s diseaseCytokine, 2015
- The role of endoscopy in inflammatory bowel diseaseGastrointestinal Endoscopy, 2015
- Crohn's diseaseThe Lancet, 2012
- Crohn's Disease and Ulcerative Colitis2012
- Platelet-derived growth factor-BB reflects clinical, inflammatory and angiogenic disease activity and oxidative stress in inflammatory bowel diseaseClinical Biochemistry, 2009